The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.

[1]  Z. Zemanová,et al.  Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? , 2004, Leukemia research.

[2]  T. Witte,et al.  Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the future , 2004 .

[3]  Z. Zemanová,et al.  A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome. , 2003, Leukemia research.

[4]  E. Stevens-Linders,et al.  Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors , 2002, Leukemia.

[5]  J. Boultwood,et al.  Clonality in the Myelodysplastic Syndromes , 2001, International journal of hematology.

[6]  U. Germing,et al.  Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. , 2000, Leukemia research.

[7]  S. E. Jacobsen,et al.  Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. , 2000, Blood.

[8]  Y. Saunthararajah,et al.  Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? , 2000, Seminars in hematology.

[9]  C. Rosenfeld,et al.  A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies , 2000, Leukemia.

[10]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  D. Gilliland,et al.  X-inactivation analysis in the 1990s: promise and potential problems , 1998, Leukemia.

[12]  B. Grandchamp,et al.  X-chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms. , 1998, Clinical chemistry.

[13]  A. Green,et al.  Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes , 1997, British journal of haematology.

[14]  R. Willemze,et al.  Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells , 1997, Leukemia.

[15]  R. Kusec,et al.  Telomere length in myelodysplastic syndromes , 1995, American journal of hematology.

[16]  D. Gilliland,et al.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. , 1996, Blood.

[17]  D. Linch,et al.  Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. , 1996, Leukemia.

[18]  R. Larson,et al.  Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. , 1996, Leukemia.

[19]  J. Prchal,et al.  A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  A. Hagemeijer,et al.  Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. , 1995, Leukemia.

[21]  B. Leber,et al.  Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.

[22]  M. Ichihara,et al.  Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. , 1994, Blood.

[23]  K. Ohyashiki,et al.  Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. , 1994, Cancer research.

[24]  A. Green,et al.  Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. , 1994, Blood.

[25]  J. Wainscoat,et al.  CLONAL ANALYSIS USING X‐LINKED DNA POLYMORPHISMS , 1993, British journal of haematology.

[26]  T. Naruse,et al.  Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X‐linked restriction fragment length polymorphisms , 1993, British journal of haematology.

[27]  R. Willemze,et al.  Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. , 1992, Blood.

[28]  J. Whittaker,et al.  Clonal lymphocytes are detectable in only some cases of MDS , 1992, British journal of haematology.

[29]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.

[30]  S. Thibodeau,et al.  Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. , 1990, Blood.

[31]  H. Heimpel,et al.  Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. , 1990, Leukemia.

[32]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[33]  A. Feinberg,et al.  Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. , 1985, Science.

[34]  P. Fialkow,et al.  Evidence for a multistep pathogenesis of a myelodysplastic syndrome. , 1984, Blood.

[35]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[36]  G. Faguet,et al.  Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell , 1981 .

[37]  P. Woolley,et al.  Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer. , 1978, Blood.

[38]  S. Gartler,et al.  Clonal origin of chronic myelocytic leukemia in man. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Lyon.  Gene Action in the X-chromosome of the Mouse (Mus musculus L.) , 1961, Nature.